You're reading the free version. Trader adds the live tape and alerts.
Start tracking
PTCT Sale Disclosure
Boulding Mark Elliott · SEC Form 4 · Filed Oct 13, 2026
Sale
Calculated transaction value
$12.34K
Boulding Mark Elliott Exec. VP And CLO
PTCT
PTC Therapeutics
PTCT
Transaction date
Oct 9, 2026
Public filing date
Oct 13, 2026
Filing lag
Filed 4 days later
PTCT daily price context
Close on/before transaction
$64.7
Oct 9, 2026
First close after public filing
$59.67
Oct 14, 2026
Return after filing · so far
+8.78%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 192 shares @ $64.26
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001578852-26-000026
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$19.91K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ptc Therapeutics, Inc. PTCT Current | Sale | Oct 9, 2026 | $12.34K |
| Ptc Therapeutics, Inc. PTCT | Exercise | Oct 9, 2026 | $7.57K |
| Ptc Therapeutics, Inc. PTCT | Exercise | Oct 9, 2026 | $0 |